Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: June 1, 2018
Reporting Period: The filing covers events occurring on June 1, 2018, specifically regarding upcoming investor presentations.
Financial Metrics
This filing does not contain specific financial data. The document serves as a disclosure notice for an investor presentation rather than a financial report. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this text.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the intent of executive officers to utilize an investor presentation (Exhibit 99.1) for upcoming meetings with investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: Executive officers plan to present material from Exhibit 99.1 to investors and analysts.
Regulatory Status: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant is identified as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Key Facts for Investor Verification
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated June 2018) for actual financial data and strategic outlook, as this 8-K only references the document.
- Confirm the company's status as an emerging growth company and its election regarding accounting standard transition periods.
- Note that the content of the investor presentation is not legally "filed" under Section 18 of the Exchange Act via this specific 8-K.